| For: | Ye JZ, Li YT, Wu WR, Shi D, Fang DQ, Yang LY, Bian XY, Wu JJ, Wang Q, Jiang XW, Peng CG, Ye WC, Xia PC, Li LJ. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis. World J Gastroenterol 2018; 24(23): 2468-2481 [PMID: 29930468 DOI: 10.3748/wjg.v24.i23.2468] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i23/2468.htm |
| Number | Citing Articles |
| 1 |
Wei-Cheng Lu, Achinto Saha, Wupeng Yan, Kendra Garrison, Candice Lamb, Renu Pandey, Seema Irani, Alessia Lodi, Xiyuan Lu, Stefano Tiziani, Yan Jessie Zhang, George Georgiou, John DiGiovanni, Everett Stone.
Enzyme-mediated depletion of serum
l
-Met abrogates prostate cancer growth via multiple mechanisms without evidence of systemic toxicity
. Proceedings of the National Academy of Sciences 2020; 117(23) doi: 10.1073/pnas.1917362117
|
| 2 |
Pierre Letourneau, Stanislas Bataille, Philippe Chauveau, Denis Fouque, Laetitia Koppe. Source and Composition in Amino Acid of Dietary Proteins in the Primary Prevention and Treatment of CKD. Nutrients 2020; 12(12) doi: 10.3390/nu12123892
|
| 3 |
Julio Plaza-Díaz, Patricio Solis-Urra, Jerónimo Aragón-Vela, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, Ana I. Álvarez-Mercado. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines 2021; 9(2) doi: 10.3390/biomedicines9020145
|
| 4 |
Jiali Chen, Fuchang Li, Weiren Yang, Shuzhen Jiang, Yang Li. Comparison of Gut Microbiota and Metabolic Status of Sows With Different Litter Sizes During Pregnancy. Frontiers in Veterinary Science 2021; 8 doi: 10.3389/fvets.2021.793174
|
| 5 |
Zhanghao Li, Feixia Wang, Baoyu Liang, Ying Su, Sumin Sun, Siwei Xia, Jiangjuan Shao, Zili Zhang, Min Hong, Feng Zhang, Shizhong Zheng. Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00349-7
|
| 6 |
Yuqiu Han, Lanjuan Li, Baohong Wang. Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives. Frontiers of Medicine 2022; 16(5) doi: 10.1007/s11684-022-0960-z
|
| 7 |
Eunju Park, Jin-Ju Jeong, Sung-Min Won, Satya Priya Sharma, Yoseph Asmelash Gebru, Raja Ganesan, Haripriya Gupta, Ki Tae Suk, Dong Joon Kim. Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease. Cells 2021; 10(10) doi: 10.3390/cells10102634
|
| 8 |
Congcong Li, Lu Wang, Juebo Zhao, Yucai Wei, Shuo Zhai, Min Tan, Kuikui Guan, Zhihong Huang, Chaoxi Chen. Lonicera rupicola Hook.f.et Thoms flavonoids ameliorated dysregulated inflammatory responses, intestinal barrier, and gut microbiome in ulcerative colitis via PI3K/AKT pathway. Phytomedicine 2022; 104 doi: 10.1016/j.phymed.2022.154284
|
| 9 |
Emmanuel Somm, Sophie A. Montandon, Ursula Loizides-Mangold, Nadia Gaïa, Vladimir Lazarevic, Claudio De Vito, Elodie Perroud, Marie-Luce Bochaton-Piallat, Charna Dibner, Jacques Schrenzel, François R. Jornayvaz. The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet. Translational Research 2021; 227 doi: 10.1016/j.trsl.2020.07.008
|
| 10 |
Sancharan Acharya, Chinnasamy Thirunavukkarasu. Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma. Frontiers in Bioscience-Landmark 2024; 29(2) doi: 10.31083/j.fbl2902067
|
| 11 |
Soo Lim, Marja‐Riitta Taskinen, Jan Borén. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. Obesity Reviews 2019; 20(4) doi: 10.1111/obr.12820
|
| 12 |
Mingmei Shao, Yifei Lu, Hongjiao Xiang, Junmin Wang, Guang Ji, Tao Wu. Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.971561
|
| 13 |
Amy S. Graham, Benneth Ben-Azu, Marie-Ève Tremblay, Peter Torre, Marjanne Senekal, Barbara Laughton, Andre van der Kouwe, Marcin Jankiewicz, Mamadou Kaba, Martha J. Holmes. A review of the auditory-gut-brain axis. Frontiers in Neuroscience 2023; 17 doi: 10.3389/fnins.2023.1183694
|
| 14 |
Hery Djagat Purnomo, Randy Adiwinata, Cecilia Oktaria Permatadewi, Hesti Triwahyu Hutami, Didik Indiarso. The global landscape of lean metabolic dysfunction-associated steatotic liver disease: insight from Asia and the West. Frontiers in Gastroenterology 2025; 4 doi: 10.3389/fgstr.2025.1699508
|
| 15 |
. 2019; doi: 10.70675/7a3e667czbdf7z4068zbadfzd850044a706a
|
| 16 |
Qiong Li, Meng Li, Fenghua Li, Wenjun Zhou, Yanqi Dang, Li Zhang, Guang Ji. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice. Journal of Ethnopharmacology 2020; 258 doi: 10.1016/j.jep.2020.112896
|
| 17 |
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, Fotis Panagopoulos, Theodora Stratigou, Eleni Geladari, Irene Karampela, Dimitrios Tsilingiris, Maria Dalamaga. The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence. Current Nutrition Reports 2024; 13(2) doi: 10.1007/s13668-024-00521-3
|
| 18 |
Isabel Cristina Mallostro Emerich de Abreu, Raquel Cristina Melo Ferreira de Albuquerque, Ana Beatriz Pereira Brandão, Leticia Barssotti, Lívia Bruni de Souza, Fabiana Gomes Ferreira, Lilian Caroline Gonçalves de Oliveira, Rodrigo Yokota, Luiz Gustavo Sparvoli, Danielle da Silva Dias, Miguel Angel Castillo Salgado, Carla Taddei, Kátia De Angelis, Dulce Elena Casarini, Tatiana Sousa Cunha. Saccharomyces boulardii exerts renoprotection by modulating oxidative stress, renin angiotensin system and uropathogenic microbiota in a murine model of diabetes. Life Sciences 2022; 301 doi: 10.1016/j.lfs.2022.120616
|
| 19 |
Gabriel Henrique Hizo, Pabulo Henrique Rampelotto. The Role of Bifidobacterium in Liver Diseases: A Systematic Review of Next-Generation Sequencing Studies. Microorganisms 2023; 11(12) doi: 10.3390/microorganisms11122999
|
| 20 |
Fen Xiong, Yingruo Xu, Xinran Wang, Yiwen Peng, Tian Tang, Kaiyuan Jiang, Ruguang Wang, Yutong Wu, Huarui Wang, Chen Li, Hongchang Gao. Apigenin ameliorates methionine-choline deficient diet-induced metabolic-associated fatty liver disease through modulation of gut microbiota-liver axis. Phytomedicine 2026; 159 doi: 10.1016/j.phymed.2026.158456
|
| 21 |
Zhongyue Zhang, Yangsheng Li, Zhen Zhang, Chenchen Wu, Sijing Chen, Dongsheng Li, Chi Liu, Tao Deng, Peiling Cai. Research Progress on Gut Microbiota and Choline: a Bibliometric Review. SN Comprehensive Clinical Medicine 2026; 8(1) doi: 10.1007/s42399-026-02588-1
|
| 22 |
Qian-Ren Zhang, Yan Dong, Jian-Gao Fan. Early-life exposure to gestational diabetes mellitus predisposes offspring to pediatric nonalcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2025; 24(2) doi: 10.1016/j.hbpd.2023.12.007
|
| 23 |
Yue Wang, Yali Deng, Nianqiang Liu, Yanggui Chen, Yuandong Jiang, Zihao Teng, Zhi Ma, Yuxue Chang, Yang Xiang. Alterations in the Gut Microbiome of Individuals With Tuberculosis of Different Disease States. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.836987
|
| 24 |
Grace Park, Sunhee Jung, Kathryn E. Wellen, Cholsoon Jang. The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease. Experimental & Molecular Medicine 2021; 53(5) doi: 10.1038/s12276-021-00614-x
|
| 25 |
Mitsuharu Matsumoto, Osamu Miura, Takeo Moriya, Hitomi Ogino, Megumi Hirayama, Akira Mitsui, Takaharu Hirayama, Yukihiko Ebisuno, Manami Kaneko, Yoshinori Satomi, Yasunori Nio. Cross-organ multi-omics profiling of microbiome and metabolome along the gut–liver axis in MASH model mice induced by western diet and MC4R knockout. Gut Pathogens 2026; 18(1) doi: 10.1186/s13099-026-00813-9
|
| 26 |
Lan-Feng Xue, Wen-Hui Luo, Li-Hao Wu, Xing-Xiang He, Harry Hua-Xiang Xia, Yu Chen. Fecal Microbiota Transplantation for the Treatment of Nonalcoholic Fatty Liver Disease. Exploratory Research and Hypothesis in Medicine 2019; 4(1) doi: 10.14218/ERHM.2018.00025
|
| 27 |
Yi-huan Chen, Jie Bai, Di Wu, Shou-fen Yu, Xiao-ling Qiang, Hua Bai, Hua-ning Wang, Zheng-wu Peng. Association between fecal microbiota and generalized anxiety disorder: Severity and early treatment response. Journal of Affective Disorders 2019; 259 doi: 10.1016/j.jad.2019.08.014
|
| 28 |
Bin Niu, Jing Liu, Hui Zhou, Weike Chu, Xue Wu, Yibing Zhou, Ze Chen, Yonggang Liu, Yuqiang Mi, Ping Li. ACT001 alleviates MASLD through gut microbiota–bile acid–FXR axis in mice. Annals of Medicine 2025; 57(1) doi: 10.1080/07853890.2025.2580773
|
| 29 |
Marica Meroni, Miriam Longo, Paola Dongiovanni. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. Nutrients 2019; 11(11) doi: 10.3390/nu11112642
|
| 30 |
Valerio Nobili, Antonella Mosca, Tommaso Alterio, Sabrina Cardile, Lorenza Putignani. Probiotics and Child Gastrointestinal Health. Advances in Experimental Medicine and Biology 2018; 1125 doi: 10.1007/5584_2018_318
|
| 31 |
Sara Lemoinne, Astrid Kemgang, Karima Ben Belkacem, Marjolène Straube, Sarah Jegou, Christophe Corpechot, Olivier Chazouillères, Chantal Housset, Harry Sokol. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut 2020; 69(1) doi: 10.1136/gutjnl-2018-317791
|
| 32 |
Maria Martin-Grau, Vannina G Marrachelli, Daniel Monleon. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?. World Journal of Hepatology 2022; 14(2): 304-318 doi: 10.4254/wjh.v14.i2.304
|
| 33 |
Yi-Yuan Xi, Chen Chen, Ju-Jia Zheng, Bing Jiang, Xin-Ya Dong, Shu-Ying Lou, Jin-Guo Luo, Xiu-Hua Zhang, Zi-Ye Zhou, Qu-Jing Luo, Wei Wang, Xu-Dong Zhou. Ampelopsis grossedentata tea alleviating liver fibrosis in BDL-induced mice via gut microbiota and metabolite modulation. npj Science of Food 2024; 8(1) doi: 10.1038/s41538-024-00334-2
|
| 34 |
Pierre S. Leclère, Déborah Rousseau, Stéphanie Patouraux, Sophie Guérin, Stéphanie Bonnafous, Aline Gréchez-Cassiau, Anthony A. Ruberto, Carmelo Luci, Malayannan Subramaniam, Albert Tran, Franck Delaunay, Philippe Gual, Michèle Teboul. MCD diet-induced steatohepatitis generates a diurnal rhythm of associated biomarkers and worsens liver injury in Klf10 deficient mice. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-69085-w
|
| 35 |
Arghya Mukherjee, Cathy Lordan, R. Paul Ross, Paul D. Cotter. Gut microbes from the phylogenetically diverse genusEubacteriumand their various contributions to gut health. Gut Microbes 2020; 12(1) doi: 10.1080/19490976.2020.1802866
|
| 36 |
Jing Guo, Ying Xu, Li-jie Chen, Song-xia Zhang, Yu-ligh Liou, Xiao-ping Chen, Zhi-rong Tan, Hong-hao Zhou, Wei Zhang, Yao Chen. Gut microbiota and host Cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: Effects vary from drug to drug. Journal of Advanced Research 2022; 39 doi: 10.1016/j.jare.2021.10.004
|
| 37 |
Guo-dong He, Xiao-cong Liu, An-shang Lu, Ying-qing Feng, Arquimedes Gasparotto Junior. Association of Choline Intake with Blood Pressure and Effects of Its Microbiota-Dependent Metabolite Trimethylamine-N-Oxide on Hypertension. Cardiovascular Therapeutics 2022; 2022 doi: 10.1155/2022/9512401
|
| 38 |
Yangie Dwi Pinanga, Kyung-hee Pyo, Eun-Ae Shin, Haesong Lee, Eun Hae Lee, Wonsik Kim, Soyeon Kim, Ji Eon Kim, Semi Kim, Jung Weon Lee. Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development. Life Sciences 2024; 358 doi: 10.1016/j.lfs.2024.123164
|
| 39 |
F. Hosseinkhani, A. Heinken, I. Thiele, P. W. Lindenburg, A. C. Harms, T. Hankemeier. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1882927
|
| 40 |
Himani Pandey, Prabudh Goel, Varunvenkat M Srinivasan, Daryl W T Tang, Sunny H Wong, Devi Lal. Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics. World Journal of Hepatology 2025; 17(6): 106849 doi: 10.4254/wjh.v17.i6.106849
|
| 41 |
Natalia Arias, Silvia Arboleya, Joseph Allison, Aleksandra Kaliszewska, Sara G. Higarza, Miguel Gueimonde, Jorge L. Arias. The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. Nutrients 2020; 12(8) doi: 10.3390/nu12082340
|
| 42 |
Hui Han, Yi Jiang, Mengyu Wang, Mebratu Melaku, Lei Liu, Yong Zhao, Nadia Everaert, Bao Yi, Hongfu Zhang. Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis. Critical Reviews in Food Science and Nutrition 2023; 63(12) doi: 10.1080/10408398.2021.1966738
|
| 43 |
Si Liu, Chaozeng Si, Yang Yu, Guiping Zhao, Lei Chen, Yu Zhao, Zheng Zhang, Hengcun Li, Yang Chen, Li Min, Shutian Zhang, Shengtao Zhu. Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome. Frontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00178
|
| 44 |
Li Wei, Chunchen Gao, Hongyan Qin. Comparison and Characteristics of MASLD Mouse Models. Biomedicines 2026; 14(4) doi: 10.3390/biomedicines14040895
|
| 45 |
Cheng-Yu Wang, Ying-Huan Hu, Zhen-Xiao Sun. Hepatic Effect of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside, the Signature
Component of Traditional Chinese Medicine Heshouwu: Advances and Prospects. Current Drug Metabolism 2023; 24(1) doi: 10.2174/1389200224666230223144826
|
| 46 |
Chuhong Su, Jiexian Wang, Huiyu Luo, Junbin Chen, Fengjuan Lin, Jiaqi Mo, Fei Xiong, Longying Zha. Gut Microbiota Plays Essential Roles in Soyasaponin's Preventive Bioactivities against Steatohepatitis in the Methionine and Choline Deficient (MCD) Diet‐Induced Non‐Alcoholic Steatohepatitis (NASH) Mice. Molecular Nutrition & Food Research 2024; 68(4) doi: 10.1002/mnfr.202300561
|
| 47 |
Jyoti Gautam, Hobby Aggarwal, Deepika Kumari, Sonu Kumar Gupta, Yashwant Kumar, Madhu Dikshit. A methionine-choline-deficient diet induces nonalcoholic steatohepatitis and alters the lipidome, metabolome, and gut microbiome profile in the C57BL/6J mouse. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2024; 1869(8) doi: 10.1016/j.bbalip.2024.159545
|
| 48 |
Gabriel Henrique Hizo, Pabulo Henrique Rampelotto. The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota. Life 2024; 14(2) doi: 10.3390/life14020239
|
| 49 |
Yuhui Yang, Guifang Cui, Jing Qian, Yuncong Xu, Bowen Li, Yonghui Shi, Guowei Le, Yanli Xie. Fecal microbiota transplantation from methionine-restricted diet mouse donors reduces fat deposition in obese mice by remodeling the gut microbiota. Food Bioscience 2024; 59 doi: 10.1016/j.fbio.2024.104255
|
| 50 |
Serena Galié, Jesús García‐Gavilán, Lucía Camacho‐Barcía, Alessandro Atzeni, Jananee Muralidharan, Christopher Papandreou, Pierre Arcelin, Antoni Palau‐Galindo, David Garcia, Josep Basora, Alejandro Arias‐Vasquez, Mònica Bulló. Effects of the Mediterranean Diet or Nut Consumption on Gut Microbiota Composition and Fecal Metabolites and their Relationship with Cardiometabolic Risk Factors. Molecular Nutrition & Food Research 2021; 65(19) doi: 10.1002/mnfr.202000982
|
| 51 |
. 2020; doi: 10.70675/936d3f01z98e8z4e8czb2b3zd5239d21aaf0
|
| 52 |
Yongmei Liu, Linda Fan, Zhuo Cheng, Lei Yu, Shuo Cong, Yaxin Hu, Lili Zhu, Baofang Zhang, Yiju Cheng, Peiling Zhao, Xueke Zhao, Mingliang Cheng. Fecal transplantation alleviates acute liver injury in mice through regulating Treg/Th17 cytokines balance. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81263-y
|
| 53 |
Carmen Rubio, Marta Puerto, Juan J. García-Rodríquez, Van B. Lu, Irma García-Martínez, Rosa Alén, Patricia Sanmartín-Salinas, M. Val Toledo-Lobo, Jorge Saiz, Javier Ruperez, Coral Barbas, Luis Menchén, Fiona M. Gribble, Frank Reimann, Luis G. Guijarro, Jose M. Carrascosa, Ángela M. Valverde. Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice. Molecular Metabolism 2020; 35 doi: 10.1016/j.molmet.2020.01.018
|
| 54 |
Tien S Dong, Jonathan P Jacobs. Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver?. Experimental Biology and Medicine 2019; 244(6) doi: 10.1177/1535370219836739
|
| 55 |
Nicolai Worm. Beyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD. Nutrients 2020; 12(5) doi: 10.3390/nu12051316
|
| 56 |
Bo Kyung Koo, Soo Lim. Clinical Obesity in Adults and Children. 2022; doi: 10.1002/9781119695257.ch13
|
| 57 |
Donglin Wu, Pengfei Zhao, Chunjie Wang, Simujide Huasai, Hao Chen, Aorigele Chen. Differences in the intestinal microbiota and association of host metabolism with hair coat status in cattle. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1296602
|
| 58 |
Hongfei Su, Jiangzheng Liu, Guangyuan Wu, Zi Long, Junshu Fan, Zhongrui Xu, Jiawei Liu, Zhongtian Yu, Meng Cao, Nai Liao, Jie Peng, Weihua Yu, Wenli Li, Hao Wu, Xin Wang. Homeostasis of gut microbiota protects against polychlorinated biphenyl 126-induced metabolic dysfunction in liver of mice. Science of The Total Environment 2020; 720 doi: 10.1016/j.scitotenv.2020.137597
|
| 59 |
María Juárez‐Fernández, Naroa Goikoetxea‐Usandizaga, David Porras, María Victoria García‐Mediavilla, Miren Bravo, Marina Serrano‐Maciá, Jorge Simón, Teresa C. Delgado, Sofía Lachiondo‐Ortega, Susana Martínez‐Flórez, Óscar Lorenzo, Mercedes Rincón, Marta Varela‐Rey, Leticia Abecia, Héctor Rodríguez, Juan Anguita, Esther Nistal, María Luz Martínez‐Chantar, Sonia Sánchez‐Campos. Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression. Hepatology 2023; 77(5) doi: 10.1002/hep.32705
|
| 60 |
Yaru Liu, Jiani Pan, Leilei Yu, Chuan Zhang, Chengcheng Zhang, Qingwei Yao, Xingxing Chen, Xuesong Wang, Jianxin Zhao, Fengwei Tian, Qixiao Zhai, Wei Chen.
Limosilactobacillus fermentum
CCFM1126 attenuates osteoporosis by modulating the gut microbiota composition and fecal metabolites: A randomized, double-blind, placebo-controlled clinical trial
. Gut Microbes Reports 2026; 3(1) doi: 10.1080/29933935.2026.2669712
|
| 61 |
Yulia A. Nevzorova, Zoe Boyer-Diaz, Francisco Javier Cubero, Jordi Gracia-Sancho. Animal models for liver disease – A practical approach for translational research. Journal of Hepatology 2020; 73(2) doi: 10.1016/j.jhep.2020.04.011
|
| 62 |
Shiting Zhao, Xiaomin Liu, Lei Li, Xinyu Kong, Wei Sun, Kerry Loomes, Tao Nie, Xiaoyan Hui, Donghai Wu. KIRA8 attenuates non-alcoholic steatohepatitis through inhibition of the IRE1α/XBP1 signalling pathway. Biochemical and Biophysical Research Communications 2022; 632 doi: 10.1016/j.bbrc.2022.09.098
|
| 63 |
Hui-su Jung, Yei Ju Park, Bon-Hee Gu, Goeun Han, Woonhak Ji, Su mi Hwang, Myunghoo Kim. Coumarin derivatives ameliorate the intestinal inflammation and pathogenic gut microbiome changes in the model of infectious colitis through antibacterial activity. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1362773
|
| 64 |
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Geladari, Maria Paraskevi Panoilia, Anna Daskou, Theodora Stratigou, Irene Karampela, Dimitrios Tsilingiris, Maria Dalamaga. NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics. Biomedicines 2024; 12(4) doi: 10.3390/biomedicines12040826
|
| 65 |
Zhangran Chen, Yurou Xie, Fei Zhou, Bangzhou Zhang, Jingtong Wu, Luxi Yang, Shuangbin Xu, Robert Stedtfeld, Qiongyun Chen, Jingjing Liu, Xiang Zhang, Hongzhi Xu, Jianlin Ren. Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.00383
|
| 66 |
Zhengjie Wu, Jian Shen, Qiaomai Xu, Qiangqiang Xiang, Yunbo Chen, Longxian Lv, Beiwen Zheng, Qiangqiang Wang, Shuting Wang, Lanjuan Li. Epigallocatechin-3-Gallate Improves Intestinal Gut Microbiota Homeostasis and Ameliorates Clostridioides difficile Infection. Nutrients 2022; 14(18) doi: 10.3390/nu14183756
|
| 67 |
Rosa M. Pascale, Maria M. Simile, Diego F. Calvisi, Claudio F. Feo, Francesco Feo. S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent. Cells 2022; 11(3) doi: 10.3390/cells11030409
|
| 68 |
Yanqun Cao, Khalid S. Ibrahim, Xing Li, Aileen Wong, Yi Wu, Xu-Dong Yu, Xinzhi Zhou, Zhoujin Tan, Zhiming He, John A. Craft, Xinhua Shu. Chinese medicine, Qijudihuang pill, mediates cholesterol metabolism and regulates gut microbiota in high-fat diet-fed mice, implications for age-related macular degeneration. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1274401
|
| 69 |
An Integrated Analysis to Understand the Dysregulation of Innate Immune Response in Mouse Models of MASLD. Cells 2026; 15(14) doi: 10.3390/cells15141298
|
| 70 |
Cássio Marques PERLIN, Larisse LONGO, Rutiane Ullmann THOEN, Carolina URIBE-CRUZ, Mário Reis ÁLVARES-DA-SILVA. COMPARISON OF GUT MICROBIOTA IN ALCOHOLIC AND METABOLIC-DYSFUNCION ASSOCIATED STEATOTIC LIVER DISEASE IN ANIMAL MODELS. Arquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612023-100
|
| 71 |
Lucrezia Irene Maria Campagnoli, Nicoletta Marchesi, Mariapia Vairetti, Alessia Pascale, Andrea Ferrigno, Annalisa Barbieri. Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention. Cells 2022; 11(18) doi: 10.3390/cells11182827
|
| 72 |
Yuhui Yang, Yanli Xie, Manman Lu, Yuncong Xu, Renyong Zhao. Contribution of dietary methionine to gut health and its related diseases: implications for precision nutrition. Critical Reviews in Food Science and Nutrition 2026; 66(3) doi: 10.1080/10408398.2025.2527425
|
| 73 |
Jiajie Li, Jingda Huang, Yanqing Lv, Huifan Ji. Association between dietary intakes of B vitamins and nonalcoholic fatty liver disease in postmenopausal women: a cross-sectional study. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1272321
|
| 74 |
Xiang Zhang, Olabisi Oluwabukola Coker, Eagle SH Chu, Kaili Fu, Harry C H Lau, Yi-Xiang Wang, Anthony W H Chan, Hong Wei, Xiaoyong Yang, Joseph J Y Sung, Jun Yu. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut 2021; 70(4) doi: 10.1136/gutjnl-2019-319664
|
| 75 |
Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1110536
|
| 76 |
Min Kyo Jeong, Byeong Hyun Min, Ye Rin Choi, Ji Ye Hyun, Hee Jin Park, Jung A Eom, Sung Min Won, Jin Ju Jeong, Ki Kwang Oh, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Sang Jun Yoon, Mi Ran Choi, Dong Joon Kim, Ki Tae Suk. Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease. Foods 2022; 11(17) doi: 10.3390/foods11172703
|
| 77 |
Shang Peng, Moran Meng, Ping Luo, Jiao Liu, Junjun Wang, Yong Chen. Tetrahydrocurcumin Alleviates Metabolic Dysfunction-Associated Steatohepatitis in Mice by Regulating Serum Lipids, Bile Acids, and Gut Microbiota. International Journal of Molecular Sciences 2025; 26(3) doi: 10.3390/ijms26030895
|
| 78 |
Qijun Chen, Tanrong Jia, Xia Wu, Xiaoqing Chen, Jiajia Wang, Yinying Ba. Polygalae Radix Oligosaccharide Esters May Relieve Depressive-like Behavior in Rats with Chronic Unpredictable Mild Stress via Modulation of Gut Microbiota. International Journal of Molecular Sciences 2023; 24(18) doi: 10.3390/ijms241813877
|
| 79 |
Yu Jung Heo, Sung‐E Choi, Nami Lee, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Yup Kang, Kwan Woo Lee, Hae Jin Kim. Visfatin exacerbates hepatic inflammation and fibrosis in a methionine‐choline‐deficient diet mouse model. Journal of Gastroenterology and Hepatology 2021; 36(9) doi: 10.1111/jgh.15465
|
| 80 |
Agnieszka Dymek, Łukasz Oleksy, Artur Stolarczyk, Anna Bartosiewicz. Choline—An Underappreciated Component of a Mother-to-Be’s Diet. Nutrients 2024; 16(11) doi: 10.3390/nu16111767
|
| 81 |
Li Jun Wang, Jian Guang Sun, Shu Cheng Chen, Yu Li Sun, Yang Zheng, Jian Chao Feng. The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1490929
|